8 Best PostEra Alternatives & Competitors (2026)

Insilico Medicine runs an AI-driven pipeline from target discovery through clinical trials, with its own proprietary generative chemistry engine. It operates both partnered and internal programs, giving sponsors clearer IP terms than PostEra’s shared-collaboration approach. Its strength lies in rapid target-to-IND timelines across oncology and fibrosis.

Exscientia combines generative AI design with automated synthesis and testing to deliver clinical candidates under sponsored programs. Unlike PostEra’s focus on medicinal chemistry within large alliances, Exscientia emphasizes integrated design-make-test cycles and has advanced multiple internal assets into the clinic.

Atomwise uses deep learning for structure-based virtual screening and lead optimization, typically delivered via project-based engagements. It offers more flexible entry points for smaller biotechs than PostEra’s multi-hundred-million-dollar alliance model while focusing tightly on small-molecule discovery.

BenevolentAI applies knowledge-graph and machine-learning methods to mine biomedical data and generate drug hypotheses. It supports both partnered and proprietary programs with full IP retention for sponsors. Its data-first approach differs from PostEra’s chemistry-centric Proton platform.

Relay Therapeutics integrates computational and experimental methods with an emphasis on protein motion for oncology targets. It runs an internal pipeline with selective partnerships, providing clearer sponsor IP ownership than PostEra’s shared-collaboration structure.

Recursion operates a large-scale phenotypic screening platform that maps cellular morphology to compound activity. Its model is more infrastructure-heavy and data-generation-oriented than PostEra’s chemistry-focused AI, suiting teams that need broad target-agnostic discovery rather than partnered medicinal chemistry.

Cyclica offers an AI-augmented platform for polypharmacology prediction and multi-target design, available through both SaaS and collaboration models. Its lighter-weight deployment contrasts with PostEra’s enterprise alliance focus and appeals to teams seeking early-stage cheminformatics support.